Flu season is right around the corner, and there's no better time than now to keep yourself from getting sick for the holidays.
The news comes as US officials are considering requiring vaccines for farm workers vulnerable to infection
New research finds that getting vaccinated in both arms can boost your immune response to covid-19 and possibly other diseases.
Children ages five to 17 years old make up the majority of those infected with the flu each year.
Researchers found a link between covid-19 and Guillain-Barré syndrome, while also finding that mRNA vaccination may lower the risk.
The CDC's advisory committee recommended this month that adults over 60 can receive one of two RSV vaccines, setting the stage for wide distribution this year.
The NIH announced the start of a new phase I trial of a potential universal flu vaccine, which uses mRNA technology.
In a large Phase III trial, GlaxoSmithKline's Arexvy substantially reduced people's risk of severe complications from respiratory syncytial virus infection.
Children who caught the common respiratory germ in infancy had a 26% higher risk of having asthma by age 5 than those who didn't.
Research found a link between little sleep and a poorer response to vaccines, though more work is needed to understand the connection.
In a bid to simplify its advice, the agency is aiming to make covid-19 vaccination similar to the yearly flu shot.
The official tally of reported covid-19 deaths is a vast undercount of the pandemic's carnage, a new study finds.
Satanic ingredients, mass death, and other debunked talking points from the anti-vaccination movement.
A new analysis from the Commonwealth Fund predicts that even a modest booster campaign would save tens of thousands of lives and billions in medical costs.
The new generation of boosters, which protect against the latest Omicron variants as well as the original coronavirus, will likely be available within weeks.
Some commonly cited estimates of long covid prevalence may be too high, but that doesn't mean it's not still a major health crisis.
The NIH-led trial will enroll up to 100 healthy adults to test a vaccine that protected mice from lethal doses of six different flu strains.
A study found that adults over 65 vaccinated for the flu were noticeably less likely to develop Alzheimer's over a four year span than those unvaccinated.
CDC data shows the vaccine was only 16% effective against the predominant strain this winter. Luckily, flu cases remained far lower than usual.
Flu-related cases, hospitalizations, and deaths were low again this winter, largely thanks to many public health measures meant to contain covid-19.
